SOURCE-LINKED STUDY SUMMARY
CARDIOVASCULAR EFFECTS OF INCRETIN RECEPTOR AGONISTS: BEYOND GLYCEMIC CONTROL.
Abstract summarizedQuality not appraised
- What was studied
- A review of cardiovascular research on single, dual and triple incretin-receptor agonists, including effects beyond blood-sugar control.
- Who / model studied
- Evidence includes isolated human heart tissue and imaging in obesity-related heart failure. The abstract gives no pooled sample size or single follow-up period.
- Studied dose & schedule
- Dose and schedule have not yet been extracted for this summary.
- What the study found
- The review reports stronger contraction in isolated atrial tissue and reverse heart-chamber remodeling with tirzepatide in obesity-related heart failure.
- Limitations & context
- For triple agonists, phase 2 findings concerned surrogate measures; phase 3 cardiovascular outcome results were still awaited.
Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1139/cjpp-2026-0184